Kraig Biocraft Laboratories (KBLB) Net Cash Flow (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Net Cash Flow across 16 years of filings, most recently posting $224544.0 for Q4 2025.

• Net Cash Flow for Q4 2025 came in at $224544.0, up 143.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $973517.0 (up 151.94% YoY), and the FY2025 annual result was $1.1 million, up 159.46% from the prior year.
• Net Cash Flow came in at $224544.0 for Q4 2025 at Kraig Biocraft Laboratories, down from $780230.0 in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $2.7 million in Q2 2021 to a low of -$973871.0 in Q3 2021.
• The 5-year median for Net Cash Flow is -$309547.0 (2023), against an average of $128603.3.
• Peak annual rise in Net Cash Flow reached 15771.56% in 2021, while the deepest fall reached 8260.84% in 2021.
• Kraig Biocraft Laboratories' Net Cash Flow stood at -$338609.0 in 2021, then slumped by 34.84% to -$456594.0 in 2022, then rose by 24.94% to -$342721.0 in 2023, then tumbled by 49.55% to -$512523.0 in 2024, then soared by 143.81% to $224544.0 in 2025.
• The last three Net Cash Flow figures came in at $224544.0 (Q4 2025), $780230.0 (Q3 2025), and $245006.0 (Q2 2025), per Business Quant data.